Background: We previously demonstrated the clinical utility of using response to therapy
variables obtained during the first 2 years of follow-up to actively modify initial risk estimates …

The thyroid nodule is a frequent cause of primary care consultation. The prevalence of a
palpable thyroid nodule is approximately 4-7%, increasing up to 67% by the incidental detection …

Background: A risk-adapted approach to management of thyroid cancer requires risk estimates
that change over time based on response to therapy and the course of the disease. The …

Background: In oncology, the clinical impact of metastatic bone disease is conveyed via a
composite end point termed skeletal-related events (SRE), which encompasses spinal cord …

The optimal management of radioactive iodine (RAI) treatment in patients with metastatic
thyroid cancer (TC) is still a matter of debate. Methods: We retrospectively analyzed 352 …

Radioiodine (RAI) refractory differentiated thyroid cancer is an uncommon and challenging
situation that requires a multidisciplinary approach to therapeutic strategies. The definition of …

Background: While radioiodine (RAI) therapy remains the most effective treatment modality
for RAI-avid distant metastatic follicular cell–derived thyroid cancer, the therapeutic utility of …

Objective To assess performance of TIRADS classification on a prospective surgical cohort,
demonstrating its clinical usefulness. Methods Between June 2009 and October 2012, …

Background: In most of the world, diagnostic surgery remains the most frequent approach for
indeterminate thyroid cytology. Although several molecular tests are available for testing in …

To evaluate the outcome of differentiated thyroid cancer (DTC) patients with biochemical
persistence of disease (BP) after initial treatment (total thyroidectomy with or without lymph …